Angiotensin II blockers in obstructive pulmonary disease: A randomised controlled trial [1]

European Respiratory Journal

Volumn 28, Issue 3, 2006, Pages 670-

  Meysman, M ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IRBESARTAN; LACTIC ACID; OXYGEN; RENIN;

ALLELE; BREATHING MUSCLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; DISEASE COURSE; EVIDENCE BASED MEDICINE; EXERCISE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LETTER; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MEDICAL LITERATURE; MUSCLE STRENGTH; OXYGEN CONSUMPTION; OXYGEN SUPPLY; PATIENT SELECTION; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SKELETAL MUSCLE; VENOUS OXYGEN TENSION; CONTROLLED CLINICAL TRIAL; ENZYMOLOGY; GENETICS; NOTE; RANDOMIZED CONTROLLED TRIAL;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; HUMANS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS;

EID: 33751281141     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00063606     Document Type: Letter

References (7)

1. Andreas S, Herrmann-Lingen C, Raupach T, et al. Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial. Eur Respir J 2006; 27: 972-979.
2. Kanazawa H, Hirata K, Yoshikawa J. Effects of captopril administration on pulmonary haemodynamics and tissue oxygenation during exercise in ACE gene subtypes in patients with COPD: a preliminary study. Thorax 2003; 58: 629-631.
3. Kanazawa H, Okamoto T, Hirata K, Yoshikawa J. Deletion polymorphisms in the angiotensin converting enzyme gene are associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 1235-1238.
4. Kanazawa H, Otsuka T, Hirata K, Yoshikawa J. Association between the angiotensin-converting enzyme gene polymorphisms and tissue oxygenation during exercise in patients with COPD. Chest 2002; 121: 697-701.
5. Kanazawa H, Hirata K, Yoshikawa J. Influence of oxygen administration on pulmonary haemodynamics and tissue oxygenation during exercise in COPD patients with different ACE genotypes. Clin Physiol Fund Imaging 2003; 23: 332-336.
6. Tkacova R, Joppa P, Stancak B, Salagovic J, Misikova S, Kalina I. The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with COPD. Wien Klin Wochenschr 2005; 117: 210-214.
7. Hopkinson NS, Nickol AH, Payne J, et al. Angiotensin converting enzyme genotype and strength in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170: 395-399.